The use of commercial video games in rehabilitation: a systematic review

B Bonnechère, B Jansen, L Omelina… - International journal of …, 2016 - journals.lww.com
The aim of this paper was to investigate the effect of commercial video games (VGs) in
physical rehabilitation of motor functions. Several databases were screened (Medline, SAGE …

Parkinson's disease in the Western Pacific Region

SY Lim, AH Tan, A Ahmad-Annuar, C Klein… - The Lancet …, 2019 - thelancet.com
Summary 1· 8 billion people of diverse ethnicities and cultures live in the Western Pacific
Region. The increasing longevity of populations in this region is a major contributor to the …

Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa

R Cilia, E Cereda, A Akpalu, FS Sarfo, M Cham… - Brain, 2020 - academic.oup.com
The natural pattern of progression of Parkinson's disease is largely unknown because
patients are conventionally followed on treatment. As Parkinson's disease progresses, the …

Does exercise attenuate disease progression in people with Parkinson's disease? A systematic review with meta-analyses

JA Li, MB Loevaas, C Guan, L Goh… - … and Neural Repair, 2023 - journals.sagepub.com
Introduction Exercise has many benefits for people with Parkinson's disease (PD) and has
been suggested to modify PD progression, but robust evidence supporting this is lacking …

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and …

JC Latourelle, MT Beste, TC Hadzi, RE Miller… - The Lancet …, 2017 - thelancet.com
Background Better understanding and prediction of progression of Parkinson's disease
could improve disease management and clinical trial design. We aimed to use longitudinal …

DAT and TH expression marks human Parkinson's disease in peripheral immune cells

A Gopinath, P Mackie, B Hashimi, AM Buchanan… - npj Parkinson's …, 2022 - nature.com
Parkinson's disease (PD) is marked by a loss of dopamine neurons, decreased dopamine
transporter (DAT) and tyrosine hydroxylase (TH) expression. However, this validation …

How should we be using biomarkers in trials of disease modification in Parkinson's disease?

N Vijiaratnam, T Foltynie - Brain, 2023 - academic.oup.com
The recent validation of the α-synuclein seed amplification assay as a biomarker with high
sensitivity and specificity for the diagnosis of Parkinson's disease has formed the backbone …

Beyond dopamine: GABA, glutamate, and the axial symptoms of Parkinson disease

RL O'Gorman Tuura, CR Baumann… - Frontiers in …, 2018 - frontiersin.org
Introduction: The axial symptoms of Parkinson disease (PD) include difficulties with balance,
posture, speech, swallowing, and locomotion with freezing of gait, as well as axial rigidity …

Ethnic variation in the manifestation of Parkinson's disease: a narrative review

A Ben-Joseph, CR Marshall… - Journal of Parkinson's …, 2020 - journals.sagepub.com
The global prevalence of Parkinson's disease is increasing, yet the characteristics, risk
factors and genetics of PD in Black, Asian and Hispanic populations is little understood. In …

Differences in MDS‐UPDRS scores based on Hoehn and Yahr stage and disease duration

M Skorvanek, P Martinez‐Martin… - Movement disorders …, 2017 - Wiley Online Library
Abstract Background The Movement Disorder Society Unified Parkinson's Disease Rating
Scale (MDS‐UPDRS) is a newly developed tool to assess Parkinson's disease (PD) …